Medication Management of Patient with Narcolepsy During Pregnancy and Lactation

Safia S. Khan, Cephas Mujuruki

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Narcolepsy is a rare neurological disorder characterized by excessive daytime sleepiness, sudden sleep attacks, sleep paralysis, hypnogogic/hypnopompic hallucinations, and loss of muscle tone triggered by emotions (in the case of narcolepsy type 1). This is a potentially debilitating disorder associated with significant loss of wages and inability to function normally if untreated. Treatment of narcolepsy is unique and challenging particularly during pregnancy and lactation. Large scale clinical trials are lacking due to the potential risk of maternal and/or fetal harm posed by the central nervous system stimulants, wake-promoting medications or the highly sedating night-time medications that improve cataplexy. Limited information is available from case reports and smaller scale mostly retrospective data analysis studies. This chapter represents the case of a young woman with Narcolepsy type 2 (without cataplexy), addressing the challenges faced during pregnancy, and after delivery of her child.

Original languageEnglish (US)
Title of host publicationA Clinical Casebook of Sleep Disorders in Women
PublisherSpringer International Publishing
Pages77-84
Number of pages8
ISBN (Electronic)9783031242007
ISBN (Print)9783031241994
DOIs
StatePublished - Jan 1 2023

Keywords

  • Cataplexy
  • Fetal risk of stimulants
  • Lactation in narcolepsy
  • Narcolepsy
  • Pregnancy

ASJC Scopus subject areas

  • General Medicine
  • General Neuroscience

Fingerprint

Dive into the research topics of 'Medication Management of Patient with Narcolepsy During Pregnancy and Lactation'. Together they form a unique fingerprint.

Cite this